Persantin Retard 200 mg Modified Release Capsules, Hard
- Licence status
- Withdrawn: 01/04/2019
- Active substances
- Dipyridamole
- Dosage Form
- Capsules Modified Release
- Licence number
- PA0007/008/007
- Licence holder
- Boehringer Ingelheim Ltd
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- B01AC Platelet aggregation inhibitors excl. heparin, B01AC07 dipyridamole
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 28/08/1998